Mangoceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022
Revenue	0.84	0.73	0.01
Revenue Growth (YoY)	670.43%	8083.16%	-
Cost of Revenue	0.32	0.3	0
Gross Profit	0.52	0.43	0
Selling, General & Admin	6.94	7.5	2
Other Operating Expenses	2.61	2.16	0
Operating Expenses	9.55	9.65	2
Operating Income	-9.03	-9.22	-1.99
Interest Expense / Income	-0	0	0.01
Other Expense / Income	-0.01	-0.01	-
Pretax Income	-9.02	-9.21	-2
Net Income	-9.02	-9.21	-2
Shares Outstanding (Basic)	23	16	11
Shares Outstanding (Diluted)	23	16	11
Shares Change	102.80%	49.22%	-
EPS (Basic)	-0.47	-0.57	-0.19
EPS (Diluted)	-0.47	-0.57	-0.19
Free Cash Flow	-6.18	-7	-1.39
Free Cash Flow Per Share	-0.27	-0.43	-0.13
Gross Margin	61.75%	58.99%	54.26%
Operating Margin	-1068.50%	-1260.28%	-22279.70%
Profit Margin	-1067.53%	-1259.40%	-22352.11%
Free Cash Flow Margin	-731.32%	-957.07%	-15545.59%
EBITDA	-9	-9.19	-1.99
EBITDA Margin	-1064.77%	-1256.00%	-22236.48%
Depreciation & Amortization	0.03	0.02	0
EBIT	-9.02	-9.21	-1.99
EBIT Margin	-1067.74%	-1259.40%	-22279.70%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).